AbbVie
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
US
IE
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
AbbVie (ABBV) Business News
Track AbbVie in real time with a live news feed covering AbbVie stock news, official press releases, company announcements, and an archive of historical AbbVie news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
Will AbbVie's Oncology Drugs Aid Top Line in 2026?
Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting®
AbbVie to Host First-Quarter 2026 Earnings Conference Call
Financial Planning Hawaii Inc. Invests $2.90 Million in AbbVie Inc. $ABBV
Brookstone Capital Management Sells 6,299 Shares of AbbVie Inc. $ABBV
Will AbbVie's Oncology Drugs Aid Top Line in 2026?
Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting®
AbbVie to Host First-Quarter 2026 Earnings Conference Call
Financial Planning Hawaii Inc. Invests $2.90 Million in AbbVie Inc. $ABBV
Brookstone Capital Management Sells 6,299 Shares of AbbVie Inc. $ABBV
Beacon Investment Advisory Services Inc. Has $19.86 Million Stock Position in AbbVie Inc. $ABBV
Chesley Taft & Associates LLC Has $5.20 Million Stake in AbbVie Inc. $ABBV
Eastern Bank Boosts Stake in AbbVie Inc. $ABBV
AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting
Here's How Many Shares of AbbVie (ABBV) Stock You'd Need for $10,000 in Yearly Dividends
Will AbbVie's Oncology Drugs Aid Top Line in 2026?
10:32 AM | Tuesday | Mar 31, 2026
ABBV's oncology lineup faces a 2026 sales dip despite rising contributions from newer drugs, as pricing pressure on Imbruvica weighs on growth.
Read full article
Will AbbVie's Oncology Drugs Aid Top Line in 2026?
Zacks Investment ResearchABBV's oncology lineup faces a 2026 sales dip despite rising contributions from newer drugs, as pricing pressure on Imbruvica weighs on growth.
Read full article
Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting®
PRNewsWireFirst-Time Users Can Claim $400 Off Their First Body Contouring Treatment. * † IRVINE, Calif.
Read full article
AbbVie to Host First-Quarter 2026 Earnings Conference Call
PRNewsWireNORTH CHICAGO, Ill., March 31, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its first-quarter 2026 financial results on Wednesday, April 29, 2026, before the market opens.
Read full article
Financial Planning Hawaii Inc. Invests $2.90 Million in AbbVie Inc. $ABBV
Defense WorldFinancial Planning Hawaii Inc. bought a new stake in AbbVie Inc. (NYSE: ABBV) in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 12,673 shares of the company's stock, valued at approximately $2,896,000. AbbVie makes up approximately 1.
7% of Financial Planning Hawaii
Brookstone Capital Management Sells 6,299 Shares of AbbVie Inc. $ABBV
Defense WorldBrookstone Capital Management cut its stake in shares of AbbVie Inc. (NYSE: ABBV) by 6.4% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 91,414 shares of the company's stock after selling 6,299 shares during the quarter. Brookstone Capital Management's holdings in
Read full article
Will AbbVie's Oncology Drugs Aid Top Line in 2026?
Zacks Investment ResearchABBV's oncology lineup faces a 2026 sales dip despite rising contributions from newer drugs, as pricing pressure on Imbruvica weighs on growth.
Read full article
Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting®
PRNewsWireFirst-Time Users Can Claim $400 Off Their First Body Contouring Treatment. * † IRVINE, Calif.
Read full article
AbbVie to Host First-Quarter 2026 Earnings Conference Call
PRNewsWireNORTH CHICAGO, Ill., March 31, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its first-quarter 2026 financial results on Wednesday, April 29, 2026, before the market opens.
Read full article
Financial Planning Hawaii Inc. Invests $2.90 Million in AbbVie Inc. $ABBV
Defense WorldFinancial Planning Hawaii Inc. bought a new stake in AbbVie Inc. (NYSE: ABBV) in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 12,673 shares of the company's stock, valued at approximately $2,896,000. AbbVie makes up approximately 1.
7% of Financial Planning Hawaii
Brookstone Capital Management Sells 6,299 Shares of AbbVie Inc. $ABBV
Defense WorldBrookstone Capital Management cut its stake in shares of AbbVie Inc. (NYSE: ABBV) by 6.4% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 91,414 shares of the company's stock after selling 6,299 shares during the quarter. Brookstone Capital Management's holdings in
Read full article
Beacon Investment Advisory Services Inc. Has $19.86 Million Stock Position in AbbVie Inc. $ABBV
Defense WorldBeacon Investment Advisory Services Inc. grew its stake in shares of AbbVie Inc. (NYSE: ABBV) by 4.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 86,896 shares of the company's stock after buying an additional 3,629 shares during the quarter.
Beacon Investment
Chesley Taft & Associates LLC Has $5.20 Million Stake in AbbVie Inc. $ABBV
Defense WorldChesley Taft and Associates LLC raised its position in AbbVie Inc. (NYSE: ABBV) by 18.2% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 22,751 shares of the company's stock after buying an additional 3,501 shares during the quarter.
Read full article
Eastern Bank Boosts Stake in AbbVie Inc. $ABBV
Defense WorldEastern Bank grew its stake in shares of AbbVie Inc. (NYSE: ABBV) by 0.7% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 380,469 shares of the company's stock after buying an additional 2,481 shares during the period. AbbVie accounts for 1.
5% of
AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting
PRNewsWireData highlights efficacy and safety of risankizumab in psoriatic disease, including high impact areas in psoriasis and long-term treatment of psoriatic arthritis Data includes real-world evidence of minimal disease activity and clinical long-term safety outcomes of upadacitinib in atopic dermatitis, as well as investigational Phase 3 data for vitiligo and alopecia areata NORTH CHICAGO, Ill., March 27, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced new research across its dermatology portfolio to be presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting, March 27–31 in Denver, Colorado.
Read full article
Here's How Many Shares of AbbVie (ABBV) Stock You'd Need for $10,000 in Yearly Dividends
The Motley FoolAbbVie has increased its dividend by more than 330% since 2013. It has a robust pipeline of drugs in development and growing revenue, too.
Read full article